The effect of the Apollo Neuro device on anxiety among participants who underwent ketamine assisted therapy.
Journal of Psychiatric Research November 1, 2025 Vivian W. L. Tsang, Brendan Tao, Raimey Olthuis et al.
In a 12-week mental health treatment program combining ketamine-assisted therapy with group support, patients who used the Apollo Neuro wearable device, which provides silent vibration touch therapy, did not show significantly greater reductions in anxiety than those who did not use the device. Anxiety was measured with the GAD-7 questionnaire. After statistically matching participants for age, sex, and baseline anxiety levels, there was no significant difference between the groups (p = 0.63). Both groups showed a median reduction in anxiety symptoms, but the device did not provide an additional benefit beyond the treatment program alone.